Genprex, Inc. Debt Instrument, Face Amount
Genprex, Inc. (GNPX) had Debt Instrument, Face Amount of $4.50 million as of 2019-03-31, per its 10-Q/A filed 2019-05-20.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2019-05-20
- 2019-03-31: Debt Instrument, Face Amount $4.50M.
- 2018-12-31: Debt Instrument, Face Amount $4.50M.
- 2018-09-30: Debt Instrument, Face Amount $4.50M.
- 2018-06-30: Debt Instrument, Face Amount $4.50M.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2019-03-31 | $4.50M 10-Q/A · filed 2019-05-20 |
| 2018-12-31 | $4.50M 10-K · filed 2019-04-01 |
| 2018-09-30 | $4.50M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $4.50M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $4.50M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $4.50M 10-K · filed 2018-04-17 |
| 2017-09-30 | $4.50M 10-Q · filed 2017-12-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |